Abstract:The Hippo signaling pathway is a highly conserved signaling network that plays a central role in regulating cellular growth, proliferation, and organ size. This pathway consists of a kinase cascade that integrates various upstream signals to control the activation or inactivation of YAP/TAZ proteins. Phosphorylated YAP/TAZ is sequestered in the cytoplasm; however, when the Hippo pathway is deactivated, it translocates into the nucleus, where it associates with TEAD transcription factors. This partnership is instrumental in regulating the transcription of progrowth and antiapoptotic genes. Thus, in many cancers, aberrantly hyperactivated YAP/TAZ promotes oncogenesis by contributing to cancer cell proliferation, metastasis, and therapy resistance. Because YAP and TAZ exert their oncogenic effects by binding with TEAD, it is critical to understand this key interaction to develop cancer therapeutics. Previous research has indicated that TEAD undergoes autopalmitoylation at a conserved cysteine, and small molecules that inhibit TEAD palmitoylation disrupt effective YAP/TAZ binding. However, how exactly palmitoylation contributes to YAP/TAZ-TEAD interactions and how the TEAD palmitoylation inhibitors disrupt this interaction remains unknown. Utilizing molecular dynamics simulations, our investigation not only provides detailed atomistic insight into the YAP/TAZ-TEAD dynamics but also unveils that the inhibitor studied influences the binding of YAP and TAZ to TEAD in distinct manners. This discovery has significant implications for the design and deployment of future molecular interventions targeting this interaction.

The Tumor Suppressor NF2 Modulates TEAD4 Stability and Activity in Hippo Signaling Via Direct Interaction

The direct interaction with transcriptional factor TEAD4 implied a straightforward regulation mechanism of tumor suppressor NF2

Tead Transcription Factors Mediate the Function of Taz in Cell Growth and Epithelial-Mesenchymal Transition

TEAD Mediates YAP-dependent Gene Induction and Growth Control

Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway

Teads Mediate Nuclear Retention of Taz to Promote Oncogenic Transformation

Structural Basis of YAP Recognition by TEAD4 in the Hippo Pathway.

The Hippo-YAP pathway: new connections between regulation of organ size and cancer.

Inactivation of Yap Oncoprotein by the Hippo Pathway is Involved in Cell Contact Inhibition and Tissue Growth Control

Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation

A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.

Structural and Functional Analysis of the YAP-binding Domain of Human TEAD 2

Cell type-dependent function of LATS1/2 in cancer cell growth

Angiomotin is a Novel Hippo Pathway Component That Inhibits YAP Oncoprotein.

Stabilization of Motin Family Proteins in NF2-deficient Cells Prevents Full Activation of YAP/TAZ and Rapid Tumorigenesis.

The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation

Integration of Mechanical and Chemical Signals by YAP and TAZ Transcription Coactivators.

Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex

Allosteric Modulation of the YAP/TAZ-TEAD Interaction by Palmitoylation and Small-Molecule Inhibitors

Small Molecule Inhibitors of TEAD Auto-palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma

The Tumor Suppressor Interferon Regulatory Factor 2 Binding Protein 2 Regulates Hippo Pathway in Liver Cancer by a Feedback Loop in Mice.